John David Ratcliffe alias The Root Cause Chiropractor

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Autoimmune and inflammatory disorders (MS, RA, Thyroid, SLE, Etc.).

Autoimmune and inflammatory disorders (MS, RA, Thyroid, SLE, Etc.)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Autoimmune and inflammatory disorders (MS, RA, Thyroid, SLE, Etc.)”

Rule: Virginia Code § 54.1-2901

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Type 1 and 2 Diabetes.

Type 1 and 2 Diabetes

Supports

No high-quality evidence in the listed papers supports chiropractic treatment as a treatment for type 1 or type 2 diabetes. The retrieved search results surfaced only low-level chiropractic case reports and non-authoritative commentary, not randomized controlled trials, systematic reviews, meta-analyses, or major diabetes guidelines demonstrating efficacy. In contrast, major diabetes guidance focuses on glucose monitoring, insulin, antihyperglycemic medications, nutrition, and coordinated medical care, not chiropractic treatment.

Contradicts

The claim is contradicted by the absence of credible clinical evidence that chiropractic care treats diabetes. The search results did not identify peer-reviewed RCTs or high-quality reviews showing improvement in HbA1c, fasting glucose, or diabetes outcomes from chiropractic manipulation, and the available chiropractic examples were anecdotal case reports that cannot establish causality. The listed guideline papers are unrelated to diabetes treatment by chiropractic care and instead reflect standard evidence-based management in other conditions, underscoring that chiropractic is not an accepted diabetes therapy.

Mainstream view

The mainstream medical and scientific view is that chiropractic care is not a treatment for type 1 or type 2 diabetes. Diabetes is managed with medical nutrition therapy, physical activity, glucose monitoring, insulin for type 1 diabetes, and evidence-based pharmacotherapy for type 2 diabetes, while chiropractic may be used only for musculoskeletal complaints if otherwise appropriate. Claims that spinal or chiropractic adjustments can treat diabetes are not supported by high-quality clinical evidence.

Papers listed for this claim:[1][2][3][4][5][6][7][8][9][10][11][12]

In their own wordsView sourceArchived copy

“Type 1 and 2 Diabetes”

Rule: Virginia Code § 54.1-2901

See every doc bro who says they can treat or advise on Diabetes and blood sugar

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Gut dysfunction (gas, bloating, IBS, SIBO, IBD, GERD/reflux, celiac).

Gut dysfunction (gas, bloating, IBS, SIBO, IBD, GERD/reflux, celiac)

Supports

The influencer’s broad statement that conditions such as gas, bloating, IBS, SIBO, IBD, GERD/reflux, and celiac represent forms of gut dysfunction is generally consistent with mainstream gastroenterology, which recognizes these as gastrointestinal disorders involving disturbances of motility, mucosal integrity, immune function, or gut–brain interaction. High‑quality evidence and guidelines define irritable bowel syndrome (IBS) as a disorder of gut–brain interaction characterized by recurrent abdominal pain with altered bowel habits, often accompanied by bloating and gas, confirming that these symptoms reflect functional gut disturbance rather than a purely structural disease process. Multiple systematic reviews and guideline‑based management reviews highlight that dietary modification (such as low‑FODMAP diet), pharmacologic therapy, and gut‑directed psychotherapies are evidence‑based approaches targeting underlying functional disturbances in IBS, which supports viewing IBS as a type of gut dysfunction rather than dismissing it as trivial. Recent systematic reviews and meta‑analyses show altered fecal short‑chain fatty acids (e.g., increased propionate, reduced acetate) in IBS and improvement with low‑FODMAP diets, reinforcing that IBS is associated with measurable changes in gut microbiota‑related metabolites and that diet can modulate these physiological abnormalities. Clinical guidelines for small intestinal bacterial overgrowth (SIBO) recognize it as a form of small intestinal dysbiosis that can produce gas, bloating, abdominal discomfort, and altered stool patterns; they recommend breath testing in selected patients and antibiotic or microbiota‑directed therapy, which is consistent with framing SIBO as gut dysfunction. Review articles and meta‑analyses further support that targeted antimicrobial or microbiota‑modulating interventions can improve symptoms and quality of life in SIBO, indicating a pathophysiologic role of abnormal small intestinal colonization. Inflammatory bowel disease (IBD) guidelines from major societies (e.g., BSG, ECCO, ACG) describe Crohn’s disease and ulcerative colitis as chronic immune‑mediated inflammatory conditions of the gut, with symptoms of diarrhea, abdominal pain, bleeding, and extraintestinal manifestations; these are prototypical examples of severe gut dysfunction, supported by extensive RCTs and biologic therapy data. Celiac disease systematic reviews and meta‑analyses show a substantial prevalence of biopsy‑proven celiac disease among IBS‑like patients and describe typical symptoms of diarrhea, bloating, and abdominal pain; this supports the view that celiac is a distinct autoimmune gut disorder that disrupts normal intestinal function and can manifest as functional‑type symptoms. Major guidelines for GERD/reflux characterize it as a chronic condition in which abnormal gastroesophageal reflux of gastric contents causes troublesome symptoms (heartburn, regurgitation) and/or complications; this fits standard definitions of esophageal and upper GI dysfunction. The Lancet review on functional dyspepsia defines it as a common disorder of gut–brain interaction involving upper‑abdominal discomfort, bloating, early satiety, and nausea in the absence of structural disease, and it discusses motility, sensory, and psychosocial mechanisms, consistent with framing dyspepsia as a type of gut dysfunction.

Contradicts

The influencer’s claim as stated is extremely broad and unspecific; high‑quality evidence and guidelines do not support lumping all of these heterogeneous conditions (IBS, SIBO, IBD, GERD, celiac, functional dyspepsia) into a single, undifferentiated entity of “gut dysfunction” for purposes of diagnosis or treatment. For example, functional dyspepsia is classified as a disorder of gut–brain interaction without structural disease, whereas IBD and celiac are immune‑mediated diseases with clear histologic and serologic markers, demanding different diagnostic work‑ups and therapies. Major IBS guidelines caution against attributing IBS‑like symptoms solely to one cause such as SIBO or celiac and emphasize the need to systematically exclude organic mimics (microscopic colitis, bile‑acid diarrhea, early IBD, exocrine pancreatic insufficiency, endocrine disorders, lactase deficiency), which contradicts oversimplified narratives that all gas, bloating, and IBS are simply one generalized gut dysfunction that can be managed with single, uniform strategies. Reviews of SIBO consistently highlight that diagnostic tests (especially breath tests) have limited specificity and sensitivity, and guideline authors grade the evidence for many SIBO interventions as very low, underscoring that SIBO is a controversial and incompletely defined construct rather than

Papers listed for this claim:[13][14][15][16][17]

In their own wordsView sourceArchived copy

“Gut dysfunction (gas, bloating, IBS, SIBO, IBD, GERD/reflux, celiac)”

Rule: Virginia Code § 54.1-2901

See every doc bro who says they can treat or advise on Autoimmune disease

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Depression/Anxiety.

Depression/Anxiety

Supports

There are no high-quality randomized controlled trials or guidelines showing that chiropractic care is an effective primary treatment for major depressive disorder or generalized anxiety disorder as standalone conditions. Available evidence for manual therapies (including osteopathic and massage) shows modest reductions in depression and anxiety scores, often in populations with chronic pain, but these data are heterogeneous and largely low-certainty. A recent systematic review and meta-analysis of manual osteopathic interventions reported small-to-moderate reductions in depression scores (Hedges g≈−0.47) and some psychophysiological changes, but emphasized substantial uncertainty and the need for more rigorous trials; effects were not specific to chiropractic spinal manipulation and were mostly in pain populations rather than primary mood disorders. Manual therapy–focused reviews on anxiety similarly suggest that some modalities (especially massage, foot reflexology, and other touch-based interventions) can reduce anxiety intensity, but the evidence quality is very low and not specific to chiropractic adjustments. Case reports and small observational studies describe individual patients with depression or anxiety who improved while receiving chiropractic care, but these cannot establish causality or generalizable efficacy.

Contradicts

Mainstream depression and anxiety treatment guidelines emphasize antidepressant pharmacotherapy, structured psychotherapies (such as cognitive behavioral therapy, interpersonal therapy, and psychodynamic therapy), and, in severe or resistant cases, neuromodulation or other psychiatric interventions; they do not recommend chiropractic care as a treatment for depressive or anxiety disorders. Evidence-based discussions of psychodynamic treatment of depression, for example, focus on psychological mechanisms and do not include spinal manipulation or chiropractic therapy as part of recommended management. High-quality trials in depression and anxiety consistently show benefit from psychotherapies, digital CBT interventions, mindfulness-based programs, and, in specific contexts, other neuromodulatory or pharmacologic strategies, with far stronger evidence than exists for chiropractic care. Compared to this body of evidence, the data for chiropractic treatment of depression/anxiety are sparse, mostly low-quality (case reports, small uncontrolled series), and often involve patients whose primary indication for chiropractic was musculoskeletal pain rather than a diagnosed mood or anxiety disorder. There are no major psychiatric, primary care, or neurology guidelines that list chiropractic care as an evidence-based treatment for depression or anxiety, and some commentary explicitly notes that current evidence does not show a clear benefit for mood and other non-musculoskeletal conditions. Overall, the lack of guideline endorsement, absence of large, rigorous RCTs, and reliance on anecdotal or indirect data contradict any strong claim that chiropractic treatment is an established or effective therapy for depression or anxiety.

Mainstream view

The mainstream medical and scientific view is that chiropractic care is a musculoskeletal-focused intervention primarily indicated for certain types of back and neck pain and some headache syndromes, not a validated treatment for depressive or anxiety disorders. For depression, recommended evidence-based treatments include antidepressant medications, structured psychotherapies (such as CBT and psychodynamic therapy), and, in selected cases, other psychiatric interventions; these approaches have substantial support from randomized trials and guideline documents. Anxiety disorders are similarly managed with psychological therapies, pharmacologic treatments, and sometimes mindfulness-based or other adjunctive interventions, all backed by robust evidence. Manual therapies, including osteopathic manipulation and massage, may be used as adjuncts in patients with chronic pain or tension-type headache, where relieving pain and improving function can secondarily alleviate mood and anxiety symptoms, but they are not considered primary treatments for mood or anxiety disorders. Major guidelines and expert reviews do not recommend chiropractic spinal manipulation as a treatment for depression or anxiety, and when manual therapy is discussed for these conditions, it is framed as exploratory, low-certainty, and adjunctive at best. In practice, if a patient with depression or anxiety receives chiropractic care for musculoskeletal complaints, any mood or anxiety improvement is regarded as secondary, uncertain, and not a substitute for standard psychiatric care.

Papers listed for this claim:[1][2][3][5][4][6][7][18][19][20][21][22]

In their own wordsView sourceArchived copy

“Depression/Anxiety”

Rule: Virginia Code § 54.1-2901

See every doc bro who says they can treat or advise on Depression

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Functional Medicine for Autoimmune/Neurological Disorders.

Functional Medicine for Autoimmune/Neurological Disorders

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Functional Medicine”

Rule: Virginia Code § 54.1-2901

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Treatment of Type 1 and 2 Diabetes.

Treatment of Type 1 and 2 Diabetes

Supports

No high-quality evidence in the listed papers supports chiropractic treatment as a treatment for type 1 or type 2 diabetes. The retrieved search results surfaced only low-level chiropractic case reports and non-authoritative commentary, not randomized controlled trials, systematic reviews, meta-analyses, or major diabetes guidelines demonstrating efficacy. In contrast, major diabetes guidance focuses on glucose monitoring, insulin, antihyperglycemic medications, nutrition, and coordinated medical care, not chiropractic treatment.

Contradicts

The claim is contradicted by the absence of credible clinical evidence that chiropractic care treats diabetes. The search results did not identify peer-reviewed RCTs or high-quality reviews showing improvement in HbA1c, fasting glucose, or diabetes outcomes from chiropractic manipulation, and the available chiropractic examples were anecdotal case reports that cannot establish causality. The listed guideline papers are unrelated to diabetes treatment by chiropractic care and instead reflect standard evidence-based management in other conditions, underscoring that chiropractic is not an accepted diabetes therapy.

Mainstream view

The mainstream medical and scientific view is that chiropractic care is not a treatment for type 1 or type 2 diabetes. Diabetes is managed with medical nutrition therapy, physical activity, glucose monitoring, insulin for type 1 diabetes, and evidence-based pharmacotherapy for type 2 diabetes, while chiropractic may be used only for musculoskeletal complaints if otherwise appropriate. Claims that spinal or chiropractic adjustments can treat diabetes are not supported by high-quality clinical evidence.

Papers listed for this claim:[1][2][3][4][5][6][7][8][9][10][11][12]

In their own wordsView sourceArchived copy

“Type 1 and 2 Diabetes”

Rule: Virginia Code § 54.1-2901

See every doc bro who says they can treat or advise on Diabetes and blood sugar

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Neurological Disorders and Neuropathy.

Neurological Disorders and Neuropathy

Supports

High-quality evidence supports the use of chiropractic spinal manipulation primarily for musculoskeletal pain conditions such as low back pain, neck pain, and some headache types, not for treating neurological disorders or neuropathy as diseases. Systematic evidence reports spinal manipulation/mobilization as effective for spinal pain and certain headache and dizziness syndromes, indicating benefit for pain modulation but not cure of underlying neurologic disease. Experimental and pilot work shows that spinal manipulation can transiently alter pain processing and brain activity, suggesting neurophysiologic effects, but these studies do not demonstrate robust clinical efficacy for neurological disorders or neuropathy. A case report and small case series show that chiropractic spinal manipulative therapy can improve symptoms in specific neurologic symptom syndromes such as notalgia paresthetica, again indicating possible symptomatic relief rather than disease modification.

Contradicts

Authoritative neurologic reviews state that there is no scientific basis for treating neurologic disorders with chiropractic manipulation and no evidence that chiropractic manipulation cures any neurologic disorder, emphasizing that available controlled studies are few and methodologically weak. Systematic review of spinal manipulation’s effects on ‘brain function’ concludes that, although changes in brain activity can be observed, the clinical relevance is unknown and it is premature to promote spinal manipulation as a treatment to improve brain function or for non-musculoskeletal conditions. Broad reviews of chiropractic efficacy find insufficient evidence to support chiropractic treatment for non-musculoskeletal conditions such as carpal tunnel syndrome and other peripheral neuropathies, with recommendations that conventional treatments should not be altered based on current chiropractic evidence. The EFNS guideline on tension-type headache management focuses on pharmacologic and other evidence-based non-pharmacologic therapies and does not recommend chiropractic manipulation as a primary treatment, illustrating that major neurology guidelines generally do not endorse chiropractic for neurologic disorders. Evidence for manual therapies or neural mobilization in diabetic peripheral neuropathy and other neuropathies is limited, low-quality, and exploratory, and these modalities are not specific to chiropractic; current data are considered insufficient for firm therapeutic recommendations. Recent trials and reviews for chemotherapy-induced and diabetic peripheral neuropathy support interventions such as compression therapy, neuromuscular or sensorimotor training, physical therapy, acupuncture, and other rehabilitative approaches, not chiropractic manipulation as a standard care option.

Mainstream view

The mainstream medical and neurologic position is that chiropractic spinal manipulation has an evidence-based role in managing certain musculoskeletal pain conditions (e.g., low back pain, neck pain, some headache types), but there is no high-quality evidence that it can treat or cure neurological disorders or neuropathy as underlying diseases. Major neurology and pain guidelines for neuropathies (diabetic, chemotherapy-induced, and other peripheral neuropathies) prioritize pharmacologic management, physical therapy, sensorimotor exercise programs, compression therapy, and modalities like acupuncture or neuromuscular training; chiropractic care is generally not included as a recommended treatment for neuropathy. Reviews in neurology explicitly state that chiropractic has no demonstrated therapeutic value beyond musculoskeletal pain and no scientific basis for treating neurologic disorders, and emphasize the lack of rigorous randomized trials supporting chiropractic for neuropathy or central neurologic disease. The prevailing view is that any neurologic symptom improvement observed with chiropractic manipulation is considered anecdotal or based on low-level evidence, and patients with neuropathy or neurological disorders should receive guideline-directed care rather than rely on chiropractic treatment as primary therapy.

Papers listed for this claim:[1][2][3][4][5][6][7][8][23][24][25][26]

In their own wordsView sourceArchived copy

“Neurological Disorders and Neuropathy”

Rule: Virginia Code § 54.1-2901

See every doc bro who says they can treat or advise on Neuropathy

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise Post Covid Long Haul Symptoms as within their scope of practice.

Post Covid Long Haul Symptoms

Supports

High-quality evidence specifically on chiropractic treatment for post-COVID/Long COVID is extremely limited. There is a single-group exploratory practice-based study that prototyped an 8–12 week chiropractic care program for long COVID patients; it was designed to test procedures and patient response, not to provide definitive efficacy data, and lacks a control group, randomization, and blinding. This provides only preliminary feasibility information, not strong support. A randomized controlled trial of thoracic spinal manipulation in long COVID patients showed that manipulation improved pulmonary function and thoracic spine mobility compared with controls. However, this was conducted within a physiotherapy college setting and focused on thoracic spinal manipulation as a physiotherapeutic intervention, not comprehensive chiropractic care, and outcomes were limited to pulmonary function and spinal mobility, not global long COVID symptom burden. More broadly, guidelines and consensus statements emphasize multidisciplinary rehabilitation, including physical therapies, supervised exercise, and symptom-titrated activity, which conceptually overlaps with some musculoskeletal and movement-based aspects of chiropractic practice, but they do not specifically endorse chiropractic care as a recommended treatment modality for long COVID. The listed paper on complementary medicine use among adults with post-COVID in the US documents that people with long COVID do use complementary approaches, which likely include chiropractic, but this describes utilization patterns rather than demonstrating efficacy. Overall, current high-quality evidence offers at best very limited and indirect support for narrow outcomes (lung function and thoracic mobility), not for broad claims that chiropractic treatment effectively treats post-COVID long-haul symptoms.

Contradicts

Major clinical practice guidelines and consensus statements for long COVID consistently state that there are no specific disease-modifying or curative treatments currently established for long COVID and that management should focus on individualized, multidisciplinary, and largely conservative symptomatic rehabilitation. These guidelines do not list chiropractic care or spinal manipulation as evidence-based core treatments and instead emphasize approaches such as personalized rehabilitation, pulmonary rehabilitation, respiratory muscle training, structured exercise, cognitive behavioral therapy (for fatigue), psychological support, and management of comorbidities. A meta-analysis of randomized controlled trials of long COVID interventions highlights exercise training, respiratory muscle training, telerehabilitation, tDCS, and specific pharmacologic or nutraceutical interventions as having measurable benefits, but chiropractic or general spinal manipulation is not included among the evaluated evidence-based interventions. The small thoracic manipulation RCT in long COVID patients, although positive for pulmonary function and mobility, is single-center, modest in size, and focused on narrow physiological endpoints, without robust data on overall symptom relief, quality of life, or long-term outcomes. The exploratory chiropractic practice-based study is uncontrolled and mainly procedural, which is far below the evidentiary standard needed to support broad therapeutic claims. Additionally, large guideline documents underscore the need to avoid unproven or potentially unsafe interventions and to prioritize evidence-based rehabilitation, implicitly cautioning against strong claims for modalities lacking robust data, such as chiropractic treatment for long COVID. Therefore, broad claims that chiropractic care effectively treats or resolves post-COVID long-haul symptoms are not supported by current high-quality evidence and run counter to the cautious, evidence-based tone of mainstream guidance.

Mainstream view

The mainstream medical and scientific position is that long COVID (post-acute sequelae of SARS-CoV-2 infection) is a complex, multisystem condition for which no single specific curative therapy has yet been established. Management is centered on careful assessment to rule out serious complications, multidisciplinary and symptom-directed rehabilitation, and supportive care, including pulmonary rehabilitation, graded or symptom-titrated physical activity, respiratory muscle training, cognitive and psychological therapies, and management of comorbidities. Recent clinical practice guidelines suggest vaccination or antivirals in the acute phase to reduce long COVID risk and support interventions such as multispecies probiotics, cognitive behavioral therapy for fatigue, and personalized rehabilitation, but they do not specifically recommend chiropractic treatment or spinal manipulation as standard care. Evidence-based reviews and meta-analyses highlight the role of structured exercise and pulmonary rehabilitation in improving cardiopulmonary function, fatigue, and quality of life. Complementary and alternative medicine, including chiropractic, is used by some patients with post-COVID conditions, but current utilization data do not equate to demonstrated efficacy and such modalities are not considered core evidence-based treatments. In summary, mainstream guidance

Papers listed for this claim:[27][28][29][30][31][32][33]

In their own wordsView sourceArchived copy

“Post Covid Long Haul Symptoms”

Rule: Virginia Code § 54.1-2901

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Unexplained fatigue.

Unexplained fatigue

Supports

There is no high-quality evidence such as randomized controlled trials, systematic reviews, or major clinical guidelines showing that chiropractic manipulation or standard chiropractic care is an effective primary treatment for unexplained fatigue, chronic fatigue syndrome, or ME/CFS. The available chiropractic literature for chronic fatigue consists mainly of case reports and small uncontrolled prospective studies (for example, an upper cervical chiropractic case series showing improved SF‑36 scores and sleep quality but without a control group or blinding), which are considered very low-quality evidence and cannot establish causality. Broader intervention research for chronic fatigue/ME‑CFS does show that some non-pharmacologic, multimodal rehabilitation approaches (e.g., nurse-led pragmatic rehabilitation, multicomponent online programs combining education, exercise, cognitive restructuring, and mindfulness) can produce small to moderate improvements in fatigue and function, but these are not chiropractic interventions and rely on structured behavioral and exercise components rather than spinal manipulation. Nutritional or complementary interventions (acupuncture/moxibustion, Chinese herbal formulas, beta‑glucan supplementation, oxaloacetate) also show some benefit in trials, but again these are unrelated to chiropractic care. Overall, there is no robust, guideline-level or RCT-level evidence specifically supporting chiropractic treatment as an effective or recommended therapy for unexplained fatigue.

Contradicts

High-quality evidence and guidelines for chronic fatigue syndrome/ME‑CFS emphasize careful diagnosis, multidisciplinary management, and generally do not include chiropractic manipulation as a recommended core treatment. Contemporary guideline-based management of chronic conditions and symptoms like fatigue stresses evidence-based interventions with graded and individualized activity management, psychological support when appropriate, and attention to nutrition and comorbidities, rather than spinal manipulation . Major nutrition and chronic disease guidelines (e.g., ASPEN-FELANPE clinical nutrition guidelines, ESPEN guidelines, parenteral nutrition appropriateness) focus on identifying specific pathophysiologic or nutritional causes of symptoms and using targeted medical nutrition therapy; they do not recommend chiropractic for symptom relief such as fatigue . The general critical literature on chiropractic notes that strong evidence is largely confined to certain musculoskeletal pain conditions (e.g., low back pain), with limited or absent high-quality data for systemic or non-musculoskeletal complaints such as chronic fatigue, raising concerns about overstated claims and non-evidence-based use for broad symptom clusters. Systematic reviews of treatments for chronic fatigue syndrome show some benefit from CBT-related therapies, graded exercise or activity management (with evolving controversy), rehabilitation, and certain complementary therapies, but they conclude there is no single consistently effective intervention and do not identify chiropractic manipulation as an evidence-based option. Overall, this body of higher-quality evidence contradicts strong claims that chiropractic treatment is a proven or guideline-endorsed therapy for unexplained fatigue.

Mainstream view

The mainstream medical and scientific position is that unexplained fatigue and ME‑CFS require careful evaluation to exclude identifiable medical, psychiatric, nutritional, sleep, and medication-related causes, followed by an individualized, multidisciplinary management plan. Evidence-based options with at least some support include structured activity management or rehabilitation, selected psychological interventions (used as supportive tools, not cures), and in some cases specific pharmacologic or nutritional approaches evaluated in trials, but no therapy is uniformly effective. Chiropractic care is not considered a standard or recommended primary treatment for unexplained fatigue or ME‑CFS in major guidelines, and any use of chiropractic is generally viewed, at best, as an adjunct addressing coexisting musculoskeletal pain or dysfunction rather than the fatigue itself. Claims that chiropractic treatment can directly and reliably resolve unexplained fatigue are regarded as unsupported by high-quality evidence and outside mainstream, guideline-driven practice.

Papers listed for this claim:[1][2][3][5][4][6][7][8][34][35][36][37]

In their own wordsView sourceArchived copy

“Unexplained fatigue”

Rule: Virginia Code § 54.1-2901

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Functional Medicine.

Functional Medicine

Supports

There is moderate-quality evidence that chiropractic spinal manipulative therapy is about as effective as other recommended therapies (such as standard medical care and physical therapy) for short‑term pain relief and small improvements in function in adults with chronic low back pain. Some randomized controlled trials show clinically meaningful reductions in pain and disability with structured courses of chiropractic spinal manipulation (around 12 sessions over 6 weeks) in chronic non‑specific low back pain, with benefits sustained up to 52 weeks. A Cochrane review and other systematic reviews indicate that for acute and subacute low back pain, combined chiropractic interventions can slightly improve pain and disability in the short and medium term compared with other treatments, though long‑term differences are minimal. Overall, high‑quality evidence supports chiropractic care as a reasonable option for musculoskeletal spinal pain (especially low back pain), broadly comparable to other conservative treatments.

Papers listed for this claim:[38][39][40][41]

In their own wordsView sourceArchived copy

“Functional Medicine”

Rule: Virginia Code § 54.1-2901

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Endocrinology.

Endocrinology

Supports

High-quality evidence does not show that chiropractic treatment can directly treat or manage endocrine diseases such as thyroid disorders, diabetes, adrenal disorders, or other core endocrinology conditions. The listed guideline papers (on hypertension, parenteral nutrition, inflammatory bowel disease, tension‑type headache, transfusion therapy, pericarditis, and GRADE methods) focus on pharmacologic, nutritional, and medical/surgical management and do not present chiropractic care as an endocrine therapy or as a recommended modality in endocrine disease pathways. Outside these references, some recent randomized trials and integrative reviews show that chiropractic spinal manipulation can acutely modulate biomarkers such as cortisol, neurotrophic factors (e.g., BDNF), and inflammatory cytokines, which are part of neuroendocrine and immune pathways. These trials suggest physiological effects on stress‑related and inflammatory signaling, but they assess short‑term biomarker changes rather than clinical outcomes in diagnosed endocrine disorders, and certainty of evidence is rated low to very low. Thus there is only indirect, mechanistic support (neuroendocrine modulation), not clinical evidence that chiropractic treatment treats endocrinology disorders.

Contradicts

A systematic review of chiropractic treatment for primary or early secondary prevention of disease found no evidence that spinal manipulation or chiropractic care prevents or halts early disease in general, undermining broad claims that chiropractic care can treat systemic medical conditions, including endocrine diseases. Major evidence‑based clinical guidelines in internal medicine, cardiology, nutrition, neurology, and transfusion practice do not list chiropractic therapy as an intervention for endocrine conditions (thyroid disease, diabetes, adrenal disease, pituitary disorders), nor as part of guideline‑directed management of hypertension, clinical nutrition for chronic disease, or pericardial inflammation. The Endocrine Society and other endocrine professional bodies issue detailed guidelines for endocrine disorders that emphasize pharmacologic therapy, hormone replacement, surgery, lifestyle interventions, and psychological support as appropriate; chiropractic care is not included as a recommended treatment for any endocrine diagnosis. In addition, existing trials of manual therapies and related complementary interventions in endocrine‑related conditions (e.g., massage in diabetes) find at most modest short‑term effects and stress that high‑quality randomized, placebo‑controlled trials are still needed, reinforcing that evidence for manual therapy as disease‑modifying endocrine treatment is weak and uncertain.

Mainstream view

The mainstream medical and scientific position is that chiropractic care is a nonpharmacologic manual therapy primarily indicated for musculoskeletal conditions, especially low back and neck pain, and not an established treatment for endocrinology disorders. High‑quality guidelines for endocrine diseases focus on hormone replacement or suppression, evidence‑based pharmacologic therapy, surgery or interventional radiology when appropriate, medical nutrition therapy, and structured lifestyle and psychological interventions; they do not recommend chiropractic treatment for endocrine diagnoses. Emerging research suggests that spinal manipulation may transiently influence neuroendocrine and inflammatory biomarkers (such as cortisol and cytokines), but these findings are preliminary, based on small RCTs with surrogate outcomes, and have not been translated into proven clinical benefits for patients with specific endocrine diseases. Professional endocrine societies and major clinical guidelines therefore do not recognize chiropractic care as a treatment for endocrinology; at most, it may be considered an adjunctive musculoskeletal therapy for patients with coexisting spine or joint pain, not a modality for correcting hormonal disorders.

Papers listed for this claim:[1][2][3][5][4][6][7][8][42][43][44][45]

In their own wordsView sourceArchived copy

“Endocrinology”

Rule: Virginia Code § 54.1-2901

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure Gastroenterology.

Gastroenterology

Supports

This search could not identify any peer-reviewed paper in the list that supports chiropractic treatment for gastroenterology conditions. The only directly relevant guideline-level paper in the list is the ESPEN guideline on clinical nutrition in inflammatory bowel disease, which addresses nutritional therapy rather than chiropractic care .

Contradicts

The claim is not supported by the listed papers, because none of them evaluate chiropractic treatment for gastrointestinal disease. The available papers are about hypertension, nutrition support, headache, parenteral nutrition, evidence grading, blood transfusion, and pericarditis, so they do not provide evidence that chiropractic treatment is effective for gastroenterology . Evidence for chiropractic treatment of gastrointestinal disorders is generally weak or absent in mainstream biomedical literature, and where studies exist they are typically low quality, indirect, or focused on symptom overlap rather than disease treatment.

Mainstream view

Mainstream medicine does not consider chiropractic treatment an evidence-based treatment for gastroenterological diseases. Standard care for GI disorders is based on diagnosis-specific therapies such as diet, medications, endoscopy, surgery when needed, and nutrition support in selected conditions, not spinal manipulation as a primary GI treatment. For inflammatory bowel disease, for example, guideline-based care emphasizes clinical nutrition and medical management rather than chiropractic intervention .

Papers listed for this claim:[1][2][3][5][4][6][7][8]

In their own wordsView sourceArchived copy

“Gastroenterology”

Rule: Virginia Code § 54.1-2901

John David Ratcliffe is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure PrimaryCare.

PrimaryCare

Supports

High-quality evidence supports limited use of chiropractic and other manual therapies for some musculoskeletal complaints (especially some forms of low back pain), as part of a broader primary care or multidisciplinary management plan, but not as a global replacement for primary care. Systematic reviews and guidelines in musculoskeletal medicine generally conclude that spinal manipulation can provide modest short-term pain relief and functional improvement in some patients with acute or subacute low back pain, when delivered by appropriately trained providers and integrated with exercise and self-management advice. Major guideline frameworks such as GRADE emphasize that even when an effect exists, the certainty of evidence for many chiropractic interventions is often low to moderate, and decisions should be made using standardized approaches to rating imprecision, bias, and consistency.

Contradicts

There is no high-quality evidence that chiropractic care can serve as comprehensive primary care for general medical conditions such as hypertension, cardiovascular disease, chronic systemic illnesses, or complex neurological disorders. Hypertension guidelines emphasize pharmacologic therapy, lifestyle modification, and risk-factor control as the foundation of care, with no role for chiropractic manipulation as a primary treatment modality. Major nutrition guidelines for inflammatory bowel disease and parenteral nutrition similarly focus on evidence-based medical, surgical, and nutritional strategies rather than chiropractic interventions. Neurology guidelines for tension-type headache stress pharmacologic and behavioral therapies, and do not recommend chiropractic manipulation as standard first‑line care. Blood transfusion practice guidelines identify specific indications and risks that require physician-led decision making and monitoring, not chiropractic management. Cardiology evidence on pericarditis and colchicine shows clear benefit from targeted pharmacologic therapy and guideline-directed evaluation, again with no established role for chiropractic as primary care. Overall, mainstream guideline documents make clear that primary care must be based on comprehensive medical assessment, preventive care, and evidence-based treatment across organ systems, which chiropractic training and scope of practice do not cover.

Mainstream view

Mainstream medical and scientific consensus is that chiropractic care is a form of complementary or allied health care focused mainly on neuromusculoskeletal problems, particularly back and neck pain. It can be appropriate as one component of care for selected musculoskeletal conditions, ideally within a coordinated team that includes primary care physicians and relevant specialists. Primary care, however, is defined as continuous, comprehensive, and coordinated medical care addressing preventive services, acute and chronic disease management, medication prescribing, and integration of specialty services, grounded in evidence-based guidelines for conditions such as hypertension, inflammatory bowel disease, headache, cardiovascular disease, and nutritional support. Chiropractors are not trained or licensed to provide the full scope of primary medical care described in these guidelines, and chiropractic manipulation is not recommended as a primary or sole treatment for systemic medical conditions in major evidence-based guidelines.

Papers listed for this claim:[1][2][3][5][4][6][7][8]

In their own wordsView sourceArchived copy

“PrimaryCare”

Rule: Virginia Code § 54.1-2901